Company: ACCO
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024931
Chunk: 207

Company: ACCO BRANDS Corp
Filing Date: 2025-02-21
Form: 10-K
Item: Item 1B
Chunk 207
---
exercise ofoutstanding options,warrants andrights(a)

    Weighted-average exerciseprice ofoutstandingoptions,warrants andrights(b)

    Number ofsecuritiesremainingavailable forfuture issuanceunder equitycompensationplans (excludingsecuritiesreflected incolumn (a)(c)

    Equity compensation plans approved by security holders

    5,711,296

    $
    8.94

    3,492,290
     
    (1)

    Equity compensation plans not approved by security holders
     
    —

    —

    —

    Total

    5,711,296

    $
    8.94

    3,492,290
     
    (1)

(1)These are shares available for grant as of December 31, 2024 under the 2022 ACCO Brands Corporation Incentive Plan, as amended (the "Plan"), pursuant to which the Compensation and Human Capital Committee of the Board of Directors or the Board of Directors may make various stock-based awards, including grants of stock options, stock-settled appreciation rights, restricted stock, restricted stock units and performance stock units. In addition to these shares, shares covered by outstanding awards under the Plan that were forfeited or otherwise terminated may become available for grant under the Plan and, to the extent such shares have become available as of December 31, 2024, they are included in the table as available for grant.

Other information required under this Item is contained in the Company’s 2025 Definitive Proxy Statement, which is expected to be filed with the SEC prior to April 4, 2025, and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Information required under this Item is contained in the Company’s 2025 Definitive Proxy Statement, which is expected to be filed with the SEC prior to April 4, 2025, and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Information required under this Item is contained in the Company’s 2025 Definitive Proxy Statement, which is expected to be filed with the SEC prior to April 4, 2025, and is incorporated herein by reference.

94

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following Exhibits are filed herewith or are incorporated by reference to exhibits previously filed with